Biofil Chemicals & Pharmaceuticals Limited

BIOFILCHEM

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202612

    Quarter₹ croreYoY
    Jun 20248+247.0%
    Sept 20242-86.1%
    Dec 202414+182.1%
    Mar 20258-45.1%
    Jun 20256-23.8%
    Sept 202514+461.3%
    Dec 20250.86-94.0%
    Mar 20268-9.4%
    Jun 202612+92.0%
  • ₹ crore

    Jun 20260.06

    Quarter₹ crore
    Jun 20240.03
    Sept 20240.02
    Dec 20240.02
    Mar 20250.24
    Jun 20253
    Sept 20250.06
    Dec 20250.08
    Mar 20260.11
    Jun 20260.06
  • ₹ crore

    Jun 202612

    Quarter₹ crore
    Jun 20248
    Sept 20242
    Dec 202414
    Mar 20259
    Jun 20259
    Sept 202514
    Dec 20250.93
    Mar 20268
    Jun 202612
  • Cost structure
  • ₹ crore

    Jun 20260.19

    Quarter₹ crore
    Jun 20240.14
    Sept 20240.18
    Dec 20240.21
    Mar 20250.25
    Jun 20250.21
    Sept 20250.18
    Dec 20250.19
    Mar 20260.22
    Jun 20260.19
  • ₹ crore

    Jun 202612

    Quarter₹ crore
    Jun 20248
    Sept 20242
    Dec 202414
    Mar 20258
    Jun 20257
    Sept 202513
    Dec 20250.83
    Mar 20267
    Jun 202612
  • Exceptional items and tax
  • ₹ crore

    Jun 20260.13

    Quarter₹ crore
    Jun 20240.23
    Sept 20240.03
    Dec 20240.22
    Mar 20250.25
    Jun 20253
    Sept 20250.11
    Dec 20250.11
    Mar 20260.47
    Jun 20260.13
  • ₹ crore

    Jun 20260.03

    Quarter₹ crore
    Jun 20240.06
    Sept 20240.01
    Dec 20240.06
    Mar 20250.05
    Jun 20250.35
    Sept 20250.03
    Dec 20250.03
    Mar 20260.26
    Jun 20260.03
  • Profit
  • ₹ crore

    Jun 20260.11

    Quarter₹ croreYoY
    Jun 20240.17-30.7%
    Sept 20240.02-80.1%
    Dec 20240.16+76.3%
    Mar 20250.20-19.7%
    Jun 20252+1324.1%
    Sept 20250.08+242.6%
    Dec 20250.08-51.9%
    Mar 20260.21+6.3%
    Jun 20260.11-95.5%
  • Per share
  • ₹ per share

    Jun 20260.07

    Quarter₹ per share
    Jun 20240.10
    Sept 20240.01
    Dec 20240.10
    Mar 20250.12
    Jun 20251.48
    Sept 20250.05
    Dec 20250.05
    Mar 20260.13
    Jun 20260.07
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
821486140.86812
Revenue YoY+247.0%-86.1%+182.1%-45.1%-23.8%+461.3%-94.0%-9.4%+92.0%
0.030.020.020.2430.060.080.110.06
821499140.93812
Cost structure
0.140.180.210.250.210.180.190.220.19
821487130.83712
Exceptional items and tax
0.230.030.220.2530.110.110.470.13
0.060.010.060.050.350.030.030.260.03
Profit
0.170.020.160.2020.080.080.210.11
Net profit YoY-30.7%-80.1%+76.3%-19.7%+1324.1%+242.6%-51.9%+6.3%-95.5%
Per share
0.100.010.100.121.480.050.050.130.07

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.